Fox Run Management, L.L.C. Amarin Corp Plcuk Transaction History

Fox Run Management, L.L.C.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 09, 2022	SELL	$3.24 - $5.18 $32,996 - $52,753	-10,184 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$3.94 - $5.84 $40,124 - $59,474	10,184 New	10,184 $52,000
Q2 2020 Jul 31, 2020	SELL	$4.78 - $8.26 $66,408 - $114,756	-13,893 Closed	0 $0
Q1 2020 May 08, 2020	BUY	$4.0 - $21.53 $55,572 - $299,116	13,893 New	13,893 $56,000
Q1 2019 Oct 17, 2019	SELL	$12.61 - $22.33 $140,853 - $249,426	-11,170 Closed	0 $0
Q4 2018 Jan 15, 2019	BUY	$12.41 - $22.98 $138,619 - $256,686	11,170 New	11,170 $152,000

176

65.1M

258K

98K

Ticker AMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 403,206,016
Market Cap $222M
Description
Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for r...

Get notified when there are updates to the investment portfolio of Fox Run Management, L.L.C., based on Form 13F filings with the SEC.

Stay updated on Fox Run Management, L.L.C. with notifications on news.